The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) this week urged Congress to maintain access to care for military families and veterans as the legislative process begins for the fiscal year 2018 National Defense Authorization Act (NDAA). In a letter to House and Senate Armed Services Committee leadership that urged no further pharmacy copayment increases, NACDS and NCPA emphasized that TRICARE beneficiaries "are concerned about being able to access the services they need. Copay increases place even greater financial burdens on TRICARE beneficiaries and unfairly penalize TRICARE beneficiaries who prefer to use local pharmacies," NACDS and NCPA wrote. The organizations cited a report by the Military Compensation and Retirement Modernization Commission that strongly recommended policies that support patient choice and access. NACDS and NCPA urged Congress, as it considers policies to control Department of Defense spending, to avoid policies like copayment increases and instead support the implementation of the "Pilot Program for Prescription Drug Acquisition Cost Parity in the TRICARE Pharmacy Benefits Program." The pilot program was included in the fiscal year 2017 NDAA and has the potential to reduce costs while also restoring TRICARE patient access to medications and services from their neighborhood pharmacies.